European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“Monday at ESTRO25 is packed with debates on the future of radiation oncology:
ESTRO–APCCC Debate (08:45–10:00 | Plenary Hall):
- ‘Local treatment intensification vs. systemic overtreatment in high-risk prostate cancer’
CBCT vs MR-Linac (15:15–16:30 | Mahler):
- ‘Could CBCT workflows replace MR-Linac?’
Head & Neck Radiation Rethink (15:15–16:30 | Plenary Hall):
- ‘Is elective nodal irradiation outdated?’
Dose Accumulation Debate (15:15–16:30 | Lehar 1-3):
- ‘Does dose accumulation have clinical value?’
Proceed to the video attached to the post.
More posts featuring ESTRO.